Xu F, Liu Z, Liu R, Lu C, Wang L, Mao W, et al. Epigenetic induction of tumor stemness via the lipopolysaccharide-TET3-HOXB2 signaling axis in esophageal squamous cell carcinoma. Cell Commun Signal. 2020;18:17 pubmed publisher

Zhou W, Wang W, Liang Y, Jiang R, Qiu F, Shao X, et al. The RNA-binding protein LRPPRC promotes resistance to CDK4/6 inhibition in lung cancer. Nat Commun. 2023;14:4212 pubmed publisher

Wang H, Haung L, Wang C, Chao Y, Hou Y, Yen C, et al. Tumor-associated macrophages promote resistance of hepatocellular carcinoma cells against sorafenib by activating CXCR2 signaling. J Biomed Sci. 2022;29:99 pubmed publisher

Jarosch S, K xf6 hlen J, Wagner S, D Ippolito E, Busch D. ChipCytometry for multiplexed detection of protein and mRNA markers on human FFPE tissue samples. STAR Protoc. 2022;3:101374 pubmed publisher

Duan X, Yang L, Wang L, Liu Q, Zhang K, Liu S, et al. m6A demethylase FTO promotes tumor progression via regulation of lipid metabolism in esophageal cancer. Cell Biosci. 2022;12:60 pubmed publisher

Ho C, Lee F, Yen T, Huang S, Cheng W. Everolimus combined with 5-aza-2-deoxycytidine generated potent anti-tumor effects on ovarian clear cell cancer stem-like/spheroid cells by inhibiting the COL6A3-AKT-mTOR pathway. Am J Cancer Res. 2022;12:1686-1706 pubmed

Shalabi S, Miyano M, Sayaman R, Lopez J, Jokela T, Todhunter M, et al. Evidence for accelerated aging in mammary epithelia of women carrying germline BRCA1 or BRCA2 mutations. Nat Aging. 2021;1:838-849 pubmed publisher

Hirao A, Sato Y, Tanaka H, Nishida K, Tomonari T, Hirata M, et al. MiR-125b-5p Is Involved in Sorafenib Resistance through Ataxin-1-Mediated Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma. Cancers (Basel). 2021;13: pubmed publisher

Hinz S, Manousopoulou A, Miyano M, Sayaman R, Aguilera K, Todhunter M, et al. Deep proteome profiling of human mammary epithelia at lineage and age resolution. iScience. 2021;24:103026 pubmed publisher

King P, Wan J, Guo A, Guo S, Jiang Y, Liu M. Regulation of gliomagenesis and stemness through acid sensor ASIC1a. Int J Oncol. 2021;59: pubmed publisher

Xin Y, Xu P, Wang X, Chen Y, Zhang Z, Zhang Y. Human foreskin-derived dermal stem/progenitor cell-conditioned medium combined with hyaluronic acid promotes extracellular matrix regeneration in diabetic wounds. Stem Cell Res Ther. 2021;12:49 pubmed publisher

Wan J, Guo A, King P, Guo S, Saafir T, Jiang Y, et al. TRPM7 Induces Tumorigenesis and Stemness Through Notch Activation in Glioma. Front Pharmacol. 2020;11:590723 pubmed publisher

Wu S, Wang H, Pan Y, Yang X, Wu D. miR-140-3p enhances cisplatin sensitivity and attenuates stem cell-like properties through repressing Wnt/β-catenin signaling in lung adenocarcinoma cells. Exp Ther Med. 2020;20:1664-1674 pubmed publisher

Chang S, Sun G, Zhang D, Li Q, Qian H. MiR-3622a-3p acts as a tumor suppressor in colorectal cancer by reducing stemness features and EMT through targeting spalt-like transcription factor 4. Cell Death Dis. 2020;11:592 pubmed publisher

Sahin I, Christodoulou M, Güzelcan E, Koyas A, Karaca C, Passarella D, et al. A small library of chalcones induce liver cancer cell death through Akt phosphorylation inhibition. Sci Rep. 2020;10:11814 pubmed publisher

Huang R, Wang S, Wang N, Zheng Y, Zhou J, Yang B, et al. CCL5 derived from tumor-associated macrophages promotes prostate cancer stem cells and metastasis via activating β-catenin/STAT3 signaling. Cell Death Dis. 2020;11:234 pubmed publisher

Xuan Z, Zhao L, Li Z, Song W, Chen J, Chen J, et al. EPS8L3 promotes hepatocellular carcinoma proliferation and metastasis by modulating EGFR dimerization and internalization. Am J Cancer Res. 2020;10:60-77 pubmed

Saga R, Matsuya Y, Takahashi R, Hasegawa K, Date H, Hosokawa Y. Analysis of the high-dose-range radioresistance of prostate cancer cells, including cancer stem cells, based on a stochastic model. J Radiat Res. 2019;60:298-307 pubmed publisher

Deshmukh A, Arfuso F, Newsholme P, Dharmarajan A. Regulation of Cancer Stem Cell Metabolism by Secreted Frizzled-Related Protein 4 (sFRP4). Cancers (Basel). 2018;10: pubmed publisher